Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 3/20 | 0.42 |
| ▸ | FLT3 | P36888 | 6/20 | 0.42 |
| ▸ | NRAS | P01111 | 5/20 | 0.42 |
| ▸ | IRAK4 | Q9NWZ3 | 5/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | IRAK1 | P51617 | 2/20 | 0.39 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31687285 | 0.86 | FLT3 (0.45) | PRKCIFLT3NRASIRAK4HRH4 | |
| SCHEMBL31687286 | 0.84 | CYP1A2 (0.47) | FLT3NRASIRAK4HRH4HRH3 | |
| SCHEMBL30833322 | 0.84 | CYP1A2 (0.47) | FLT3NRASIRAK4HRH4HRH3 | |
| SCHEMBL31687300 | 0.84 | CYP1A2 (0.43) | PRKCIFLT3NRASHRH4HRH3 | |
| SCHEMBL31634664 | 0.84 | CYP1A2 (0.43) | PRKCIFLT3NRASHRH4HRH3 | |
| Hydrochloric Acid SCHEMBL30457682 | 0.83 | CYP1A2 (0.46) | FLT3NRASIRAK4HRH4HRH3 | |
| SCHEMBL1031708 | 0.78 | PRKCI (0.51) | PRKCIIRAK4 | |
| SCHEMBL1031709 | 0.78 | PRKCI (0.51) | PRKCIIRAK4 | |
| SCHEMBL31687296 | 0.77 | CYP1A2 (0.46) | PRKCIFLT3NRASIRAK4HRH4 | |
| Hydrochloric Acid SCHEMBL28555877 | 0.76 | PRKCI (0.50) | PRKCIIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4620955-A1 | MC4R ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL USE THEREOF | Changchun Genescience Pharmaceutical Co., Ltd. (CN) | 2025-09-24 | — | — | EP | disclosed |